407
Views
2
CrossRef citations to date
0
Altmetric
Polycystic ovary syndrome

Depression, anxiety, body image scores, and sexual dysfunction in patients with polycystic ovary syndrome according to phenotypes

, , ORCID Icon &
Pages 849-855 | Received 18 Mar 2022, Accepted 24 Aug 2022, Published online: 11 Sep 2022

References

  • Asunción M, Calvo RM, San Millán JL, et al. A prospective study of the prevalence of polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85(7):2434–2438.
  • Lizneva D, Suturina L, Walker W, et al. The criteria, prevalence and phenotypes of PCOS. Fertil Steril. 2016;106(1):6–15.
  • Azziz R, Woods KS, Reyna R, et al. The prevalence and features of polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745–2749.
  • Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84(11):4006–4011.
  • Yildiz BO, Bozdag G, Yapici Z, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067–3073.
  • Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–2855.
  • Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2(2):16057.
  • Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine F, and Merriam GR, editors. Polycystic ovary syndrome., Boston, MA: Blackwell Scientific Publications; 1992. p. 377–384.
  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS). Hum Reprod. 2004;19:41–47.
  • Azziz R, Carmina E, Dewailly D, Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488.
  • Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38.e25.
  • Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
  • Legro RS, Arslanian SA, Ehrmann DA, Endocrine Society, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–4592.
  • Dokras A, Clifton S, Futterweit W, et al. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2011;117(1):145–152.
  • Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26(9):2442–2451.
  • Dokras A, Clifton S, Futterweit W, et al. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2012;97(1):225–230.e222.
  • Veltman-Verhulst SM, Boivin J, Eijkemans MJ, et al. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012;18(6):638–651.
  • Kogure GS, Ribeiro VB, Lopes IP, et al. Body image and its relationships with sexual functioning, anxiety, and depression in women with polycystic ovary syndrome. J Affect Disord. 2019;253:385–393.
  • Dokras A, Stener-Victorin E, Yildiz BO, et al. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018;109(5):888–899.
  • Hisli N. Beck Depresyon Envanterinin üniversite öğrencileri için geçerlilik ve güvenilirliği. Türk Psikoloji Dergisi. 1989;7:3–13.
  • Aydemir Ö, Güvenir T, Küey L v a Hastane anksiyete ve depresyon ölçeği Türkçe formunun geçerlilik ve güvenilirliği. Türk Psikiyatri Dergisi. 1977;8:280–287.
  • Oksuz E, Malhan S. Reliability and validity of female sexual function index in Turkish population. Sendrom. 2005;17:54–58.
  • Kılıç C. Genel Sağlık Anketi: Geçerlik ve güvenirlik çalışması. Türk Psikiyatri Dergisi. 1996;7:3–11.
  • Hovardaoğlu S. Vücut Algısı Ölçeği. Psikiyatri Psikoloji Psikofarmakoloji. 3P. 1993;1(Ek 2):26–27.
  • Cesta CE, Månsson M, Palm C, et al. Polycystic ovary syndrome and psychiatric disorders: co-morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology. 2016;73:196–203.
  • Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075–1091.
  • Moran LJ, Deeks AA, Gibson-Helm ME, et al. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod. 2012;27(7):2082–2088.
  • Fatemeh B, Shahideh JS, Negin M. Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study. J Ovarian Res. 2021;14(1):57.
  • Cinar N, Kizilarslanoglu MC, Harmanci A, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod. 2011;26(12):3339–3345.
  • Behboodi Moghadam Z, Fereidooni B, Saffari M, et al. Measures of health-related quality of life in PCOS women: a systematic review. Int J Womens Health. 2018;10:397–408.
  • Barnard L, Ferriday D, Guenther N, et al. Quality of life and psychological wellbeing in polycystic ovary syndrome. Hum Reprod. 2007;22(8):2279–2286.
  • Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol. 2006;22(2):80–86.
  • Jones GL, Palep-Singh M, Ledger WL, et al. Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study. Health Qual Life Outcomes. 2010;8:149.
  • Dilbaz B, Cınar M, Ozkaya E, et al. Health-related quality of life among different PCOS phenotypes of infertile women. J Turkish German Gynecol Assoc. 2012;13(4):247–252.
  • Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol. 2007;66(3):373–379. DOI:10.1111/jog.14478.
  • Zhang D, Gao J, Qin H, et al. Phenotypic features and fertility outcomes of women with polycystic ovary syndrome: the effect of quality of life. J Obstet Gynaecol Res. 2020. Online ahead of print.
  • Annagür BB, Tazegül A, Akbaba N. Body ımage, self-esteem and depressive symptomatology in women with polycystic ovary syndrome. Noro Psikiyatr Ars. 2014;51(2):129–132.
  • Alur-Gupta S, Chemerinski A, Liu C, et al. Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety. Fertil Steril. 2019;112(5):930–938.e1.
  • Deeks AA, Gibson-Helm ME, Paul E, et al. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. 2011;26(6):1399–1407.
  • Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol. 2006;11(4):613–625.
  • De Niet JE, de Koning CM, Pastoor H, et al. Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod. 2010;25(6):1497–1503.
  • Pastore LM, Patrie JT, Morris WL, et al. Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women. J Psychosom Res. 2011;71(4):270–276.
  • Geiss IM, Umek WH, Dungl A, et al. Prevalence of female sexual dysfunction in gynecologic and urogynecologic patients according to the international consensus classification. Urology. 2003;62(3):514–518.
  • Veras AB, Bruno RV, de Avila MAP, et al. Sexual dysfunction in patients with polycystic ovary syndrome: clinical and hormonal correlations. Compr Psychiatry. 2011;52(5):486–489.
  • Ercan CM, Coksuer H, Aydogan U, et al. Sexual dysfunction assessment and hormonal correlations in patients with polycystic ovary syndrome. Int J Impot Res. 2013;25(4):127–132.
  • Firmino Murgel AC, Santos Simões R, Maciel GAR, et al. Sexual dysfunction in women with polycystic ovary syndrome: systematic review and meta-analysis. J Sex Med. 2019;16(4):542–550.
  • Loh HH, Yee A, Loh HS, et al. Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis. Hormones (Athens). 2020;19(3):413–423.
  • Zhao S, Wang J, Xie Q, et al. Is polycystic ovary syndrome associated with risk of female sexual dysfunction? A systematic review and metaanalysis. Reprod Biomed Online. 2019;38(6):979–989.
  • Pastoor H, Timman R, de Klerk C, et al. Sexual function in women with polycystic ovary syndrome: a systematic review and Meta-analysis. Reprod BioMed. 2018;37(6):750–760.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.